🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Suitability of a High-energy, Low-protein Formula (Renalive® LP)

RecruitingNAAges 18 Years - anyAllFresenius Kabi Taiwan Ltd.
NCT06892249 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Inclusion criteria (1) Diagnosed with chronic kidney disease stage 3b-5 (with history of eGFR\<45 mL/min/1.73 m2) Exclusion criteria (1) Has received dialysis or are expected to start dialysis within the next 3 months.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: (1) Diagnosed with chronic kidney disease stage 3b-5 (with history of eGFR\<45 mL/min/1.73 m2) Exclusion Criteria: (1) Has received dialysis or are expected to start dialysis within the next 3 months
💊

What it tests

  • Renalive® LP,
📍

Where

2 sites
Kaosiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan
Taipei TzuChi Hospital
New Taipei City, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy